The Harvard research funding crisis has emerged as a pivotal moment for the university's groundbreaking initiatives, particularly at the Wyss Institute led by Don Ingber.Following the Trump administration's controversial funding freeze of approximately $2.2 billion, vital projects—including groundbreaking organ-on-a-chip technology—are now jeopardized, putting both innovation and national progress at risk.